GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
50.33
-0.08 (-0.16%)
Nov 6, 2026, 4:00 PM EST - Market closed

GSK Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
33,54332,66731,37630,32829,32424,696
Revenue Growth
4.28%4.12%3.46%3.42%18.74%1.40%
Cost of Revenue
8,8028,9478,8458,3889,4078,033
Gross Profit
24,74123,72022,53121,94019,91716,663
Selling, General & Admin
9,1179,01310,8479,1568,1796,784
Research & Development
7,3076,6546,0785,8235,1534,627
Other Operating Expenses
-1,928-1,394-584-1,442-737-382
Operating Expenses
14,49614,27316,34113,53712,59511,029
Operating Income
10,2459,4476,1908,4037,3225,634
Interest Expense
-713-658-615-710-819-762
Interest & Investment Income
1261471321086213
Earnings From Equity Investments
-101-3-5-233
Other Non Operating Income (Expenses)
-21-21-63-74-44-6
EBT Excluding Unusual Items
9,6278,9165,6417,7226,5194,912
Merger & Restructuring Charges
-410-109-354-383-323-424
Gain (Loss) on Sale of Investments
-24-2457-1212561
Gain (Loss) on Sale of Assets
10610624661215552
Asset Writedown
-2,336-888-320-398-296-347
Legal Settlements
----922-
Other Unusual Items
-1,580-600-1,793-817-1,665-1,095
Pretax Income
5,3837,4013,4776,0645,6283,599
Income Tax Expense
5611,11252675670783
Earnings From Continuing Operations
4,8226,2892,9515,3084,9213,516
Earnings From Discontinued Operations
----10,4951,069
Net Income to Company
4,8226,2892,9515,30815,4164,585
Minority Interest in Earnings
-471-573-376-380-460-200
Net Income
4,3515,7162,5754,92814,9564,385
Net Income to Common
4,3515,7162,5754,92814,9564,385
Net Income Growth
-20.80%121.98%-47.75%-67.05%241.07%-23.73%
Shares Outstanding (Basic)
4,0164,0514,0774,0524,0264,003
Shares Outstanding (Diluted)
4,0804,1174,1424,1114,0844,052
Shares Change
-1.37%-0.60%0.75%0.66%0.79%0.55%
EPS (Basic)
1.081.410.631.223.711.10
EPS (Diluted)
1.071.390.621.203.661.08
EPS Growth
-19.72%123.15%-48.12%-67.26%238.48%-24.16%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
7,4226,3935,1555,4546,2607,002
Free Cash Flow Per Share
1.821.551.251.331.531.73
Dividend Per Share
0.6900.6600.6100.5800.6131.000
Dividend Growth
7.81%8.20%5.17%-5.31%-38.75%0%
Gross Margin
73.76%72.61%71.81%72.34%67.92%67.47%
Operating Margin
30.54%28.92%19.73%27.71%24.97%22.81%
Profit Margin
12.97%17.50%8.21%16.25%51.00%17.76%
Free Cash Flow Margin
22.13%19.57%16.43%17.98%21.35%28.35%
EBITDA
11,49211,3358,31910,5079,2937,756
EBITDA Margin
34.26%34.70%26.51%34.64%31.69%31.41%
D&A For EBITDA
1,2471,8882,1292,1041,9712,122
EBIT
10,2459,4476,1908,4037,3225,634
EBIT Margin
30.54%28.92%19.73%27.71%24.97%22.81%
Effective Tax Rate
10.42%15.02%15.13%12.47%12.56%2.31%
Advertising Expenses
-738851835735433
SEC Filings: 10-K · 10-Q